Israel - Tiếng Anh - Ministry of Health

padagis israel pharmaceuticals ltd, israel - testosterone - gel - testosterone 25 mg/dose - testosterone - testosterone - testosterone replacement therapy for males hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.

Israel - Tiếng Anh - Ministry of Health

padagis israel pharmaceuticals ltd, israel - testosterone - gel - testosterone 50 mg/dose - testosterone and estrogen - testosterone and estrogen - testosterone replacement therapy for males hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.

Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - buserelin - solution for injection - 1 milligram(s)/millilitre - gonadotropin releasing hormone analogues; buserelin

Singapore - Tiếng Anh - HSA (Health Sciences Authority)

viatris private limited - eplerenone - tablet, coated - 25 mg - eplerenone 25 mg

Singapore - Tiếng Anh - HSA (Health Sciences Authority)

viatris private limited - eplerenone - tablet, coated - 50 mg - eplerenone 50 mg

Singapore - Tiếng Anh - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - cyproterone acetate - tablet - 50 mg - cyproterone acetate 50 mg

Vương quốc Anh - Tiếng Anh - MHRA (Medicines & Healthcare Products Regulatory Agency)

besins healthcare (uk) ltd - progesterone - oral capsule - 200mg

Armenia - Tiếng Anh - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

bionorica se - agnus castus dry extract - tablets film-coated - 4mg

Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

laboratoires besins international - progesterone - capsule, soft - 100 milligram(s) - progesterone

Israel - Tiếng Anh - Ministry of Health

cts ltd - progesterone micronized - capsules - progesterone micronized 200 mg - progesterone - progesterone - vaginal administration: progesterone substitution for ovary deprived women in situation of total progesterone deficiency. supplementation of the luteal phase during in vitro fertilization cycles. supplementation of the luteal phase during spontaneous or induced cycles, in cases of hypofertility or primary or secondary ovarain failure, particulary through dysovulation. in cases of threatning abortion or prevention of repeated abortions due to proven luteal insufficiency. for all other progesterone indication, in the case of : adverse events due to progesterone, contraindication of the oral route of administration hepatopathy. vaginal or oral addministration: disorders related to progesterone deficit in particular menopause ( in association with estrogen therapy).